Engineered Nanofiber‐Based Nerve Guidance Conduit Facilitates the Restoration of Peripheral Nerve Injury Through Enhanced Vascularization

Why It Matters

By integrating vascularization cues with structural guidance, the ECd@PCL conduit could overcome donor‑site limitations of autografts and speed functional recovery for peripheral nerve injuries, a sizable unmet medical need.

Key Takeaways

• ECd@PCL scaffold combines physical guidance and biochemical cues
• Enhances axon growth in PC12 cells in vitro
• Accelerates myelin formation and motor recovery in rat model
• Provides alternative to autologous grafts with limited donors
• Electrospun nanofibers promote vascularization supporting nerve regeneration

Pulse Analysis

Peripheral nerve injuries affect millions worldwide, often leaving patients with lasting motor and sensory deficits. Traditional autologous nerve grafts remain the clinical gold standard, yet they are constrained by donor availability, morbidity at harvest sites, and variable outcomes. Recent advances in tissue engineering emphasize the importance of recreating both the physical architecture and the vascular microenvironment essential for nerve regeneration. By focusing on angiogenesis, researchers aim to supply the metabolic support that enables axonal sprouting and myelination, addressing a critical gap in current repair strategies.

The ECd@PCL nerve guidance conduit leverages electrospinning to produce aligned PCL nanofibers that mimic the native extracellular matrix’s topography. An endothelial cell‑derived matrix (ECd) is deposited via electrospray, furnishing the scaffold with pro‑angiogenic proteins and growth factors. In vitro assays demonstrate that PC12 cells extend longer neurites on ECd@PCL than on bare PCL, while co‑culture models reveal enhanced signaling between neurons and supporting cells. This dual‑mode functionality—mechanical alignment plus biochemical stimulation—creates a conducive niche for nerve tissue to regenerate.

In vivo, the conduit was implanted across a 12‑mm sciatic nerve gap in rats, a defect size that typically exceeds the capacity of simple tubular conduits. Animals receiving ECd@PCL NGCs showed faster myelin sheath formation, improved electrophysiological parameters, and superior gait recovery compared with untreated controls. These findings suggest that integrating vascular cues can substantially shorten the timeline for functional restoration. If translated clinically, such bio‑active conduits could reduce reliance on donor nerves, lower surgical complications, and open new market opportunities for regenerative medicine companies targeting peripheral neuropathies.